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Summary
Most transmembrane proteins are selected as transport vesicle cargo through the recognition of 
short, linear amino acid motifs in their cytoplasmic portions by vesicle coat proteins. In the case of 
clathrin-coated vesicles (CCVs) the motifs are recognised by clathrin adaptors. The AP2 adaptor 
complex (subunits α,β2,μ2,σ2) recognises both major endocytic motifs: YxxΦ motifs 1 and 
[DE]xxxL[LI] acidic dileucine motifs. Here we describe the binding of AP2 to the endocytic 
dileucine motif from CD4 2. The major recognition events are the two leucine residues binding in 
hydrophobic pockets on σ2. The hydrophilic residue four residues upstream from the first leucine 
sits on a positively charged patch made from residues on σ2 and α subunits. Mutations in key 
residues inhibit the binding of AP2 to ‘acidic dileucine’ motifs displayed in liposomes containing 
PtdIns4,5P2, but do not affect binding to YxxΦ motifs via μ2. In the ‘inactive’ AP2 core 
structure 3, both motif binding sites are blocked by different parts of the β2 subunit. To allow a 
dileucine motif to bind, the β2 N-terminus is displaced and becomes disordered; however, in this 
structure the YxxΦ binding site on μ2 remains blocked.
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In CCVs, cargo is mainly selected through the recognition of one of three types of signal by 
clathrin adaptors: the short, linear, transplantable peptide motifs that are widely found on 
general cargo; covalently attached ubiquitin molecules (reviewed in 4); and the folded 
determinants on SNARE proteins 5,6. The two major classes of transplantable motifs used in 
CCVs are the YxxΦ and acidic dileucine motifs. The latter can be divided into two further 
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classes: the [ED]xxxL[LI] motifs, which, along with YxxΦ motifs, are recognised by the 
heterotetrameric AP clathrin adaptor complexes on numerous different pathways (reviewed 
in 7 and references therein); and the DxxLL motifs, recognised by GGAs for TGN-to-
endosome transport 8,9. AP2 plays a pivotal role in regulating the formation of endocytic 
CCVs destined for early endosomes. Whilst the mechanism of YxxΦ motif binding by APs 
has been characterised at the molecular level, there is no mechanistic insight into 
[DE]xxxL[LI] binding, although several recent studies indicate that the binding site resides 
on the α/σ2 heterodimer 10,11. Eight different ‘acidic dileucine’ peptides were tried in co-
crystallisation experiments with the 200kDa AP2 core and several produced poorly-
diffracting crystals. However, co-crystallisation with the peptide RM(phosphoS)QIKRLLSE 
(Q peptide) from the T-cell cell-surface antigen protein CD4, and a variant of this peptide 
(RM(phosphoS)EIKRLLSE) (E peptide), resulted in crystals that diffracted to resolutions of 
3.0Å and 3.4Å respectively. The structure of the Q peptide complex was solved by 
molecular replacement using models derived from the closed structure 3 see Figure 1. 
Rebuilding of the α and β2 helical solenoids was required due to alterations in their overall 
curvature (see later), but even in the initial electron density maps the ‘dileucine peptide’ 
could be seen clearly. The identity and orientation of the peptide was confirmed as described 
in online Materials and Methods.
The structure shows that the peptide binds in an extended conformation near the α subunit 
binding site for PtdIns4,5P2, which is replaced here by two sulphate ions (see Figures 1 & 4 
and Figure S3). The LL moiety at positions L0 and L+1 (for nomenclature see 7 and Figure 
S1b) binds in two adjacent hydrophobic pockets on the small σ2 subunit that are lined by a 
number of hydrophobic residues (see Figure 2), most of which are conserved in all σ 
subunits from APs 1-4 in species from yeast to mammals (Figure 3 and Supplementary 
Information). Mutation of a number of these to hydrophilic residues (σ2L65S, σ2V88D, 
σ2V98S or σ2L103S), or filling in the pocket by replacement of σ2A63 or σ2N92 with 
tryptophan, strongly inhibited binding of recombinant AP2 core complexes to different 
dileucine motifs displayed on PtdIns4,5P2 - containing liposomes (Table S1, online 
Materials and Methods and 12). The KD for wild-type AP2 binding to the CD4 dileucine 
motif was 0.85 μM, whilst the σ2V88 and σ2L103 mutations reduced binding to below 
detectable levels. A double mutant in σ2R15 and αR21 decreased binding to the dileucine 
motif by around an order of magnitude, with the KD for σ2R15S/σ2R21E reduced to 7.8 μM. 
In contrast, the binding of wild-type and mutant AP2 cores to PtdIns4,5P2 and to YxxΦ was 
unaffected, with KDs for binding to the TGN38 YxxΦ motif between 0.31μM and 0.38 μM, 
indicating that all recombinant core variants were correctly folded and functional (Figure 3).
The L-4 position of AP2-binding dileucine motifs is most commonly occupied by the acidic 
residues glutamate or aspartate, but other residues are possible, such as glutamine (as in the 
human CD4 dileucine motif used here), histidine (in feline CD4) or arginine (in GLUT4) 
(reviewed in 7). The binding of the residue in the L-4 position occurs on a hydrophilic patch 
with an overall positive charge. The electron density for its side chain is not as strong as that 
for the two leucine residues or the peptide backbone, indicating some degree of flexibility in 
binding. Indeed, simultaneous mutation of two basic residues in the patch (αR21 and 
σ2R15) were necessary to reduce dileucine motif binding significantly (Figure 3). In the E 
peptide where the L-4 position is the more commonly found glutamate 7, the electron 
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density is similar to that for the corresponding glutamine in the Q peptide complex (see 
supplementary information). The use of general electrostatic complementarity rather than a 
specific side chain/side chain interaction is supported by the fact that exchange of a motif’s 
L-4 glutamate to a shorter aspartate has little effect on binding of dileucine motifs to AP2 11. 
This general electrostatic interaction probably assists in correctly orienting the peptide, a 
proposal supported by the observations that mutation of the L-4 acidic residue to an alanine 
significantly weakens but does not abolish binding, whereas mutation to a positively charged 
arginine abrogates binding altogether in the context of the sequence EDEPLL 11. Consistent 
with this we observed a slightly weaker binding of AP2 to the Q peptide compared to the E 
peptide (see data in Table S2). Intriguingly, however, in GLUT4 transporters (RRTPSLL), 
the L-4 and L-5 positions of the internalisation motifs are arginine residues (reviewed in 7); 
suggesting that AP2 might possess alternate modes of dileucine motif binding that would 
likely utilise the same dileucine moiety binding pocket but could place the remainder of the 
peptide in a different location. Taken together, these structural and mutagenesis data explain 
the inhibition of the endocytosis of dileucine motif-containing cargoes when the key L[LI] 
and [ED] residues are mutated 11,13,14.
Point mutation and motif-swapping indicates that the identity of the residues in the L-1 to 
L-3 positions have some effect on motif binding 10,11. In the structure presented here the 
arginine in the L-1 position interacts with σ2N97. A proline, often found at this position, 
would increase the strength of binding by favouring the conformation of the peptide 
backbone observed in the bound peptide 14. In this AP2:CD4 peptide complex the −2 and −3 
position residue side chains point into solvent away from the AP2 surface. In vivo, however, 
the conformational context of the motif may be affected by these and other surrounding 
residues, as has been proposed for the L-5 position phosphorylated serine residue, which has 
no visible electron density for the phosphate in the structures presented here, despite its 
presence as confirmed by mass spectrometry (data not shown). The apparent lack of 
sequence specificity for residues other than the L[LI] moiety which is manifest in the 
increased tolerance of AP2 for alterations in residues adjacent to the L[LI] as compared with 
AP1 and AP3 11, is reflected in the lack of strong contacts between non L[LI] residues of the 
motif and AP2 displayed here. Such comparatively broad specificity, as is shown by the 
similar binding affinities displayed by AP2 for a number of different ‘acidic dileucine’ 
motifs (see Supplementary Table S2), may ensure the efficient internalisation of dileucine 
motif-containing proteins that arrive at or mis-sort to the cell surface. The ability of the other 
AP complexes to discriminate between different L[LI] signals may be necessary to ‘fine 
tune’ the directing of cargoes to different intracellular compartments.
In the closed and therefore inactive conformation of AP2 3, the hydrophobic L[LI] binding 
pockets are occupied by side chains from residues in the N-terminal extension to the first 
helix of the β2 subunit. β2F7 occupies the deep L pocket whilst β2Y6 lies in the broader and 
shallower L+1 L[LI] pocket (Figure 4 and Figure S8c). Phosphorylation of β2Y6 by 
EGFR 15 would inhibit the binding of β2Y6 in the L+1 pocket and so greatly weaken the 
interaction between the N-terminus of β2 and σ2. In the overall structure of the 
heterotetrameric complex has the helical solenoids of the α and β2 chains form a puckered 
ring around σ2 and the N-terminal domain of μ2 (N-μ2), which together make a bowl for the 
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C-terminal domain of μ2 (C-μ2). Comparing this dileucine motif-liganded, unlocked 
structure with the ‘inactive’ conformation, the α/β2 ring splits approximately as two rigid 
bodies, α(1-400)/σ2 and α(401-end)/β2/N-μ2, with a relative rotation of ~20° about a point 
near residue α400. This widens the opening of the ring at the N-terminus of β2, and the N-
terminal extension swings away into solvent, thus exposing the peptide binding site. C-μ2 
forms a third rigid body, bridging between α and β2, and roughly preserving its contacts 
with both α and β2, such that the YxxΦ binding site on μ2 remains blocked by β2V365 and 
β2Y405. In the case of AP1, and very likely therefore also in AP2, it has been proposed that 
binding of either an acidic dileucine or YxxΦ motif drives a conformational change that 
favours the binding of the other motif 16. Therefore, a further conformational change must 
occur in order to produce a fully active conformation that is able to bind both types of motif 
and PtdIns4,5P2 simultaneously. The failure to attain a fully active ‘open’ conformation is 
driven by a combination of factors including crystal packing, the lack of a YxxΦ peptide to 
compete out the autoinhibitory binding of β2 to μ2 and the high concentration of ammonium 
sulphate in the crystallisation conditions which will increase the apparent strength of the 
interaction between β2V365 and the C-μ2 Φ residue binding pocket and which also helps to 
stabilise the interaction of β2 residues 350 and 500 with C-μ2.
The binding site on σ2 used by AP2 to bind acidic dileucine motifs is not the same as that 
used by other proteins with σ2 or ‘longin domain’ folds to bind their cognate ligands: these 
include the SNAREs Sec22b 17 and Vamp7 5 and the signal recognition particle SRα 
subunit 18. Intriguingly, however, the hydrophobic L[LI] binding pocket, but not the −4 
position acidic residue binding patch, is largely conserved in the ζCOP subunit of the β, γ, δ, 
ζ subcomplex of COPI that is homologous in structure to AP complexes (PDB 2HF6 and 
supplementary information), pointing to a possible conservation of function in the binding of 
a di-hydrophobic motif, candidates for which would include the FF motif of the COPI 
cargoes, the p24 family and ERGIC-53 19 and the N-terminus of β-COP.
The mechanism of the binding of a dileucine motif by the AP2 clathrin adaptor complex 
conforms to the established paradigm of a CCV/cargo interaction. The peptide is bound in 
an extended conformation by a folded adaptor domain, with specificity arising from a few 
residue side chains fitting into compatible pockets. The mode of binding is therefore 
superficially similar to the binding of DxxLL motifs by the VHS domains of GGAs 8,9 but 
the design of the LL and acidic residue recognition pockets, their spacing, and the structures 
underlying them are completely different (see figure S9). The interaction between the two 
isolated components, a dileucine motif-containing peptide molecule and a single AP2 
complex, is dynamic with a KD in the micromolar range (1-3 μM) 12 and buries around 
1100Å2 of solvent accessible surface area, which are both similar to the values demonstrated 
for other cargo/clathrin adaptor interactions 6. When the signal is presented in, and so co-
recognised with, a PtdIns4,5P2 -containing membrane, the apparent strength of the 
interaction with AP2 is increased with the KD dropping into the high nM range as shown 
here and it is this coincidence detection of PtdIns4,5P2 and acidic dileucine motif that allows 
the signal to outcompete the N-terminus of β2 for binding to σ2. It is also the requirement 
both for co-recognition with PtdIns4,5P2 and a conformational change that prevents 
inappropriate recognition of dileucine and also YxxΦ sequences in the cytoplasm.
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Online Materials and Methods
Expression, crystallisation & structure solution
The four subunits of the AP2 core (1-621 mouse α-adaptin; 1-591 human β2-adaptin; 1-435 
rat μ2-adaptin, 1-143 mouse σ2-adaptin) were co-expressed in E. coli from two bicistronic 
plasmids of different (ampicillin and kanamycin) antibiotic resistances as in 3 in E. coli 
BL21DE3 pLysS cells at 22°C. Protein expression was allowed to continue for 14 hours, the 
cells harvested, lysed using a Cell Disrupter (Constant Cell Disruption Systems) and 
insoluble material removed by centrifugation. AP2 was purified throughout in 10mM Tris 
pH 8.7, 250mMNaCl, 1mM DTT. The complex was bound to glutathione sepharose 
(Pharmacia), the column extensively washed and the complex eluted by overnight cleavage 
at 20°C with bovine thrombin (Sigma). The resulting AP2 complex was bound to NiNTA 
agarose (Quiagen), the column extensively washed and the complex eluted with buffer 
containing 0.3M imidazole. The complex was then purified by gel filtration on Superdex 
S200 (Pharmacia) and finally passed back down a glutathione sepharose column to remove 
any remaining uncleaved GST-AP2 complex. The yield was 1-2 mg of purified AP2 per litre 
of culture.
Crystals of the CD4 peptide/AP2 core complexes were grown over a period of three weeks 
by hanging drop vapour diffusion against a reservoir containing 1.7-2.2M ammonium 
sulphate, 100mM sodium citrate pH6.5 and 5mM DTT from a mixture of 10mg/ml AP2 core 
and 7mg/ml peptide. The best crystals had dimensions of around 200⌠m and diffracted to a 
best resolution of 3.0Å. Crystals were cryoprotected with 1.8-2.3M ammonium sulphate, 
100mM sodium citrate pH 6.5, 17% glycerol and 7mg/ml CD4 dileucine peptide. Data were 
collected at 100K on Diamond beamline I03, integrated using Mosflm 21, scaled with 
Scala 22. The crystals belong to space group P43212 with two molecules in the asymmetric 
unit. The structure was solved by molecular replacement using Phaser 20, with models 
derived from the IP6-liganded ‘inactive’ AP2 core structure (3 PDB code 2vgl). Extra 
electron density representing the peptide bound to the σ2 subunit was clear from the first 
maps after molecular replacement (figure S1). The final model refined at 3.0Å resolution 
comprises residues 3-623 of α (missing 1-2 and including a final 2 residues from the cloning 
linker), 12-582 of β2 (missing 1-11 and 583-591), 1-142 of σ2 (missing none), and residues 
1-141 and 159-435 of μ2 (missing 142-158, as well as the loop 223-231 which are also 
missing in the structure of isolated C-μ2), the dileucine peptide, sulphates and waters. For 
statistics relating to the data collection and structure solution see Table 1 and for a sample of 
typical electron density see FigureS2.
The orientation and registration of the RMS(P)QIKRLLSE peptide in this density was 
decided as follows. (1) There were clearly two pockets for hydrophobic residues, one deep 
and one shallow. Electron density consistent with leucine side chains could be seen in each 
pocket, but the orientation of the backbone connecting them could be in either direction. (2) 
The electron density for the peptide extends for about 4 or 5 residues on one side of the deep 
pocket, but not more than 1 or 2 on the other side of the shallow pocket: since the LL 
sequence is only two residues from the C-terminus of the peptide, the longer part of the 
density must be N-terminal to the LL sequence. This places the invariant first L in the deep 
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pocket, and the conserved second L (which can also be I or M) in the shallower pocket. With 
this model of the peptide, the structure refined well, showing good density for the residues 
SQIKRLLS (see Figure 2), but no density for the phosphate moiety of the phophoserine 
(S(P)) side chain, which was therefore modelled as a serine, although mass spectrometry of 
a sample of peptide incubated in crystallisation conditions for 2 weeks confirmed that the 
serine residue remained phosphorylated. The lack of density for the phosphate is likely to be 
caused by static disorder of the phosphate group. The structure was refined using 
Phenix.refine 23 with default tight NCS restraints between the two molecules, and rebuilt 
with Coot 24. Large positive difference density peaks close to Arg or Lys side chains were 
interpreted as SO42− ions, given the crystallisation conditions in 2M (NH4)2SO4, and a few 
well resolved waters were added to the model (Figure S3). TLS group assignment used the 
TLSMD server (http://skuld.bmsc.washington.edu/~tlsmd/) 25 splitting the α chain into 6 
groups, the β2 chain into 5, the μ2 chain into 2 groups and the σ2 chain as 1 group. 
Refinement without TLS gave slightly higher Rfactors (Rwork 0.222, Rfree 0.266) but little 
difference in the maps (map correlation 0.99, 0.93 at 3Å resolution). Ramachandran analysis 
of the final model showed 86% of residues in the most favoured region, 96% in “allowed” 
regions.
The structure of a complex between the AP2 core and a version of the CD4 acidic dileucine 
motif peptide termed “E-peptide” in which the L-4 Q residue was replaced with an E (ie 
RMSpEIKRLLSE) was also solved. The “E-peptide” dataset was of lower quality than the 
best Q peptide data set. The crystal used to collect the Q-peptide dataset gave better 
diffraction than the many others which were tried, and also had the serendipitous advantage 
of rotating approximately around the long c axis, which reduced the spot overlap compared 
to rotation around an axis roughly perpendicular to the long axis, as for the E-peptide 
crystal. The final model from the Q-peptide after the Q to E substitution was refined against 
the E-peptide data, with & without the peptide: as expected, the map quality was poorer than 
for the Q-peptide, but there was no significant difference in the structure. The electron 
density for the peptide shows no evidence of any difference in conformation (figure S4), nor 
are the residues contacting the E side chain noticeably different: in particular, the side chain 
density for αR21 is still very weak. The lack of crystallisability of other AP2 core:dileucine 
motif peptide complexes is likely be explained by the packing interaction that occur in the 
crystal between the L-1 position arginine in the peptide and the side chain of β2Glu157 and 
the backbone amide of β2Q154
Peptides sequences, conjugation of peptides to lipid and liposome and analyte 
preparation
The following peptides were coupled to lipid for incorporation into liposomes, which were 
then used in the SPR-based binding experiments:
TGN 38* CKVTRRPKASDYQRL,
Phosphorylated CD4 Q peptide CHRRRQAERM(SP)QIKRLLSEK
Phosphorylated CD4 E peptide CHRRRQAERM(SP)EIKRLLSEK
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Peptides with and asterisk were also synthesized with mutations in their critical sorting 
relevant amino acid residues (Y to A in TGN 38 and pairs of alanine residues substituting 
for the two leucine residues in dileucine containing peptides) and served as negative 
controls.
Coupling of peptides to MPB-PE and the subsequent incorporation into liposomes were 
performed as described in 12. In brief, peptides were covalently linked via their amino-
terminal cysteine to 1,2-dipalmitoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-
maleimidophenyl) butyramide], Avanti, USA. The lipid-linked peptide was subsequently 
incorporated into 100nm liposomes that were composed of 60% PC, 20%PE, 10% 
PtdIns4,52 and 10% peptido-lipid. The efficiency of peptide coupling was determined by 
mass spectrometry and the integrity of the liposomes was controlled by dynamic light 
scattering. The average variation of the PtdIns4,5P2 content between different liposome 
preparations was less than 3% as determined by binding of the ENTH domain of Epsin1 
(See figure S5).
Peptido-liposomes were used to generate a stable “membrane mimic” on a L1sensorsurface 
of a BIAcore 3000 (BIAcore AB, Sweden) SPR biosensor. The system was first equilibrated 
in 10mM Tris pH 8.7, 250mM NaCl 1mM DTT, which was used as the running buffer 
followed by priming with two injections of 20mM CHAPS for 1min (flow rate 10μl/min) 
and injection of the liposomes (0.25 mM final concentration) for 4min at 5μl/min. Loosely 
bound liposomes were removed by two pulse injections of 50mM sodium hydroxide for 
30sec at 30μl/min. This procedure resulted in an increase of the baseline by app. 9500 RU 
with less than 4% variation between the four flow-cells. After liposome capture, wild type 
and mutant AP2 cores were injected at concentrations ranging from 50nM to 1μM at a flow 
rate of 30μl/min for one min (association) followed by buffer flow for 4 min (dissociation). 
All protein that did not dissociate within this period from the membrane was stripped off by 
a 20sec pulse injection of 50mM NaOH. In a typical experiment the sensor surface was 
derivatized with basic liposomes (PC/PE) in flow-cell 1, PC/PE+ PtdIns4,5P2 in flow cell 2, 
PC/PE+ PtdIns4,5P2 +TGN38 peptide in flow-cell 3 and with PC/PE+ PtdIns4,5P2 
+phosphoCD4 peptide in flow-cell 4. This set up allowed to differentiate between 
background binding to PC/PE liposomes, binding to PtdIns4,5P2 and PtdIns4,5P2 together 
with a sorting signal containing peptide. In other experiments TGN38 and LRP dileucine 
sorting signal containing peptido-liposomes were compared with liposomes containing 
mutant versions of both peptides in which the critical tyrosine or both leucine residues were 
substituted for alanine. This setup was used to control binding of AP2 to a mutated sorting 
signal in a PtdIns4,5P2 containing membrane (not shown). The kinetic analysis of binding 
was carried out exactly as described 26 and rate constants were calculated using the 
Evaluation software supplied by the manufacturer (BIAcore evaluation software 27). All 
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GST-AP2 complexes used in the SPR binding assay expressed to similar levels and were 
checked for intactness and folding by SDS PAGE and circular dichroism prior to use. A 
typical Coomassie Blue stained SDS PAGE gel of AP2 cores used in the SPR-based assay is 
shown in figure S5. The samples are actually those used in the determination of KDs shown 
in Figure 3 in the main text.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Structure of the AP2 adaptor core in complex with the dileucine peptide from CD4
Orthogonal views of the dileucine motif liganded AP2 complex in ribbon (a and b) and in 
molecular surface (c and d) representations. In a and c the membrane is parallel to the upper 
face of the complex and in b and d the complex is viewed through the membrane with the 
membrane interacting surface facing up. The α subunit is coloured dark blue, β2 green, σ2 
pale blue, N-μ2 purple and C-μ2 mauve. The dileucine motif peptide, shown as spheres with 
carbons coloured gold. The two sulphate groups bound to the α subunit in the PtdInsP2 site 
are shown.
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Figure 2. Details of binding of the CD4 dileucine signal by the σ2 and α subunits of AP2
a The dileucine peptide is bound mainly by the pale blue σ2 subunit near its interface with 
the α subunit (dark blue). The peptide is shown in its final 2mFo-dFc electron density 
(cropped around the peptide and contoured at 0.11 e/Å3).
b Schematic representation of the dileucine peptide with the principal side chains involved 
in its binding. Mutants in the boxed residues were kinetically analysed.
c and d details of the polar Q(L-4) binding pocket: d with semi transparent electrostatic 
surface representation (coloured from red −0.5V to blue +0.5V), showing the positive 
charge principally due to αR21, σ2K13 and σ2R15.
e and f: the deep and shallow pockets on σ2 involved in recognising the leucine residues at 
position L0 and L+1. Labelled side chains are in the σ2 subunit unless otherwise indicated.
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Figure 3. Confirmation of location and conservation amongst different σ subunits of the 
dileucine motif binding site
a The dileucine peptide binding site with residues whose mutation strongly inhibit dileucine 
peptide binding whilst not affecting YxxΦ motif binding are coloured red (See 
Supplementary Table S1 and Figure S8).
b and c Sensorgrams and KD values for binding of wild type AP2 core and three mutants 
thereof that strongly inhibit binding of AP2 to PtdIns4,5P2 containing liposomes displaying 
the CD4 Q peptide motif (b) but do not effect binding to PtdIns4,5P2 containing liposomes 
displaying the TGN38 YxxΦ motif (c).
d Mammalian σ2, σ1a, σ3 and σ4 were aligned using ClustalW (Figure S7) and the residue 
conservation plotted from dark purple (absolute conservation) to white (no conservation) 
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onto the surface of mammalian σ2 in two views related by a rotation of 180°. The binding 
site for the dileucine motif peptide is the outstanding feature of surface residue conservation.
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Figure 4. A conformational change in AP2 is required for dileucine peptide binding
In the IP6-liganded inactive conformation (a) the N-terminus of β2 is held in place by β2F7 
and β2Y6 sitting in the L0 and L+1 pockets. For dileucine motifs to bind the N-terminus of 
β2 is displaced from the surface of σ2 (b). (c) close-up view of the dileucine binding site: 
note that the LL peptide (gold) runs in the opposite direction to the N-terminus of β2 
(green). (d) Schematic representation of the conformational change: a 20° hinge movement 
in α moves the N-terminus of β2 out of the LL-binding site, allowing the motif to bind. The 
μ2 subunit has been omitted for clarity. (e) front & back views of the conformational 
change: the IP6-liganded inactive conformation is shown in pale colours, the unlocked 
dileucine-peptide bound conformation in dark colours. The YxxΦ site on μ2 remains 
blocked, and is remote from the dileucine binding site.
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Table 1
Data collection & refinement statistics
Dataset Q peptide E peptide
Space group, unit cell (a, c) P43212, 169.9, 321.7 Å P43212, 171.2,324.3 Å
Wavelength 0.976 Å 0.976 Å
Rotation range (nearest axis to spindle) 112° (c*) 114° (a*)
Resolution range Å (high resolution) 51–3.0 (3.16-3.0) 47-3.4 (3.58-3.40)
Rmerge 0.198 (1.17) 0.195 (0.96)
Rmerge in top intensity bin 0.050 0.058
Rmeas 0.223 (1.32) 0.212 (1.06)
Rpim 0.102 0.079 (0.42)
Number of observations (unique) 853264 (96683) 410234 (64153)
< <Ih> / ⌠(<Ih>) > 8.6 (1.8) 7.8 (1.9)
Completeness 100.0% (100.0%) 95.8% (89.1%)
Multiplicity 8.8 (9.0) 6.4 (5.0)
Wilson <B> 60Å2 58 Å2
Refinement
Rwork 0.204 (0.33) 0.24 (0.33)
Rfree 0.261 (0.37) 0.267 (0.38))
Number of reflections (test set) 183747 (9168) 116095 (5902)
RMSD bonds (angles) 0.007Å (1.1°) 0.009Å (1.3°)
Number of TLS groups 28 28
<Biso> (peptides) 79Å2 (84Å2) 86Å2 (108Å2)
Number of atoms 28125 28125
Number of sulphate ions (waters) 34 (26) 34 (26)
Rmerge = ©hl | Ihl - <Ih> | / ©hl <Ih> ; Rmeas = ©hl [nh/( nh-1)]1/2 Ihl - <Ih> | / ©hl <Ih>
Rpim = ©hl [1/(nh-1)]1/2 Ihl - <Ih> | / ©hl <Ih> where nh is the number
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